Candida glabrata and Candida krusei
|
|
| Species identification
|
|
| Amphotericin B
|
|
| Flucytosin
|
|
| Fluconazole The action of fluconazole against C.glabrata is poor (MIC 8-64 mg/L) and against Candida kruzei insufficient (MIC >32 mg/L). Susceptibility testing of these species is not warranted. Candida glabrata with MIC <32 mg/L may be available for therapy with high fluconazole dosages. |
|
| Itraconazole
|
|
| Voriconazole
|
|